| Report ID | 281526 |
| Drug Identification Number | 02473887 |
| Brand name | GLYCOPYRROLATE INJECTION USP |
| Common or Proper name | GLYCOPYRROLATE INJECTION USP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GLYCOPYRROLATE |
| Strength(s) | 4MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 1 VIAL X 20 ML |
| ATC code | A03AB |
| ATC description | DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2026-03-26 |
| Estimated end date | 2026-05-22 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-03-26 |
| Company comments | Contract coverage is in place. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-26 | French | Compare |
| v1 | 2026-03-26 | English | Compare |
Showing 1 to 2 of 2